Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Promising phase Ib/IIa data on OBP-601 in HIV

Sep. 15, 2010

YM-150 is safe and tolerated in phase II trial in nonvalvular atrial fibrillation

Sep. 15, 2010

Cara Therapeutics' CR-09 shows promise in preclinical study

Sep. 15, 2010

Bristol-Myers Squibb generates backup IGF-I receptor inhibitor to BMS-754807 for cancer

Sep. 15, 2010

Ensemble Therapeutics describes Ensemblins

Sep. 15, 2010

GNE-A shows preclinical potential as anticancer agent

Sep. 15, 2010

Clinical data on sevuparin in healthy adults support evaluation in phase II trial in malaria

Sep. 14, 2010

Omecamtiv mecarbil improves left atrial contractility in healthy males

Sep. 14, 2010

New partial 5-HT3 receptor agonist described for treatment of IBS

Sep. 14, 2010

MEDI-578 has analgesic effects in rat model of inflammatory pain

Sep. 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.